
|Videos|November 13, 2013
Drug Pipeline Activity: Hepatitis C
We will see a new wave of oral antiviral hepatitis C medicines hitting the market towards the end of this year and the beginning of next year, noted Aimee Tharaldson, PharmD, senior clinical consultant, Emerging Therapeutics, Express Scripts.
Advertisement
We will see a new wave of oral antiviral hepatitis C medicines hitting the market towards the end of this year and the beginning of next year, noted Aimee Tharaldson, PharmD, senior clinical consultant, Emerging Therapeutics, Express Scripts.
This video was shot at the 2013 Academy of Managed Care Pharmacy Nexus meeting in San Antonio, Texas.
BONUS:
For more information about HCV therapies, read this
Advertisement
Advertisement
Advertisement
Trending on Pharmacy Times
1
Closing the Calcium Gap: How Pharmacists Can Guide Patients Toward Better Bone Health
2
COVID-19 Vaccination in Medically Complex Adults
3
Testing categories in practice — clinical conversations
4
The Vaccine Schedule Just Changed Again—Here’s What's Real and What Isn't
5






































































































